Financials

v3.24.1.1.u2
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 6,159 $ 6,760
Restricted cash 13
Receivables 134 46
Notes receivable 1,000
Prepaid expenses and other current assets 318 199
Total current assets 6,611 8,018
Property and equipment, net 3 5
Operating lease right-of-use asset, net 32 63
Total assets 6,646 8,086
Current liabilities:    
Accounts payable 371 348
Note payable to related party 500
Other accrued liabilities 155 519
Operating lease liability, current 33 65
Deferred grant revenue 12
Total current liabilities 559 1,444
Total liabilities 559 1,444
Stockholders’ equity (deficit):    
Preferred stock, at amounts paid in, $0.001 par value per share; 5,000,000 shares authorized, 950,000 shares issued and outstanding at March 31, 2024 and December 31, 2023. 1 1
Common stock, at amounts paid in, $0.001 par value per share; 225,000,000 shares authorized, 914,234 and 781,503 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively. 1 1
Additional paid-in capital 398,975 398,470
Accumulated deficit (392,890) (391,830)
Total stockholders’ equity 6,087 6,642
Total liabilities and stockholders’ equity $ 6,646 $ 8,086

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.24.1.1.u2
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Total revenues $ 98
Operating expenses:    
Research and development 561
General and administrative 1,063 1,234
Total operating expenses 1,063 1,795
Loss from operations (1,063) (1,697)
Other income:    
Interest income, net 1 22
Other income, net 2
Other income, net 3 22
Net loss $ (1,060) $ (1,675)
Basic net loss per common share $ (1.24) $ (2.23)
Diluted net loss per common share $ (1.24) $ (2.23)
Weighted average shares used in computing basic net loss per common share 853 751
Weighted average shares used in computing diluted net loss per common share 853 751
Grant [Member]    
Revenues:    
Total revenues $ 98

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.24.1.1.u2
CONDENSED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (1,060) $ (1,675)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2 43
Stock-based compensation 290
Other (1)
Changes in operating assets and liabilities:    
Notes receivable 1,000
Receivables (87) 18
Prepaid expenses and other assets (119) (99)
Accounts payable 22 (70)
Deferred grant revenue (12) (98)
Other accrued liabilities (358) (308)
Net cash used in operating activities (613) (1,899)
Net decrease in cash, cash equivalents and restricted cash (613) (1,899)
Cash, cash equivalents and restricted cash at beginning of period 6,772 3,133
Cash, cash equivalents and restricted cash at end of period 6,159 1,234
Supplemental cash flow information:    
Interest paid 13
Note payable to related party converted to common stock 500
Accrued interest net of tax converted to common stock 5
Cash and cash equivalents 6,159 1,136
Restricted cash 98
Cash, cash equivalents and restricted cash shown in the condensed statements of cash flows $ 6,159 $ 1,234

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL